Lobe Sciences Ltd. (LOBE.CN)
CAD 0.02
(-42.86%)
CAD 0.02
(-42.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.4 Million CAD | -340.71% |
| 2022 | -11.96 Million CAD | -87.72% |
| 2021 | -6.15 Million CAD | 693.16% |
| 2020 | -2.7 Million CAD | 54.94% |
| 2019 | -383.39 Thousand CAD | -2727.53% |
| 2018 | -148.4 Thousand CAD | -185.72% |
| 2017 | -51.93 Thousand CAD | -47.22% |
| 2016 | -35.28 Thousand CAD | -174.03% |
| 2015 | 47.65 Thousand CAD | 143.92% |
| 2014 | -108.49 Thousand CAD | 20.87% |
| 2013 | -137.11 Thousand CAD | -45.12% |
| 2012 | -94.48 Thousand CAD | -3.83% |
| 2011 | -91 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -523.1 Thousand CAD | 54.19% |
| 2024 Q3 | -562.12 Thousand CAD | 33.57% |
| 2024 Q2 | -556.6 Thousand CAD | -5.28% |
| 2023 FY | - CAD | -340.71% |
| 2023 Q1 | -2.23 Million CAD | -427.96% |
| 2023 Q3 | -341.26 Thousand CAD | 74.47% |
| 2023 Q4 | -42.91 Thousand CAD | 87.43% |
| 2023 Q2 | -1.33 Million CAD | 40.23% |
| 2022 Q3 | 83.04 Thousand CAD | -92.11% |
| 2022 FY | - CAD | -87.72% |
| 2022 Q4 | -423.59 Thousand CAD | -610.1% |
| 2022 Q1 | 2.29 Million CAD | -76.27% |
| 2022 Q2 | 1.05 Million CAD | -54.05% |
| 2021 FY | - CAD | 693.16% |
| 2021 Q2 | -2.43 Million CAD | -118.93% |
| 2021 Q3 | 5.29 Million CAD | 317.57% |
| 2021 Q1 | -1.11 Million CAD | -119.49% |
| 2021 Q4 | 9.65 Million CAD | 82.15% |
| 2020 Q3 | -17.52 Thousand CAD | 97.92% |
| 2020 Q1 | -524.21 Thousand CAD | -138.96% |
| 2020 FY | - CAD | 54.94% |
| 2020 Q4 | -506.79 Thousand CAD | -2792.35% |
| 2020 Q2 | -844.02 Thousand CAD | -61.01% |
| 2019 Q1 | -111.76 Thousand CAD | -623.91% |
| 2019 Q2 | -51.95 Thousand CAD | 53.52% |
| 2019 Q3 | -3.99 Million CAD | -7591.6% |
| 2019 Q4 | 1.34 Million CAD | 133.67% |
| 2019 FY | - CAD | -2727.53% |
| 2018 Q3 | -8491.00 CAD | 33.15% |
| 2018 Q2 | -12.7 Thousand CAD | 34.69% |
| 2018 FY | - CAD | -185.72% |
| 2018 Q1 | -19.44 Thousand CAD | -119.2% |
| 2018 Q4 | -15.43 Thousand CAD | -81.83% |
| 2017 Q3 | -14.6 Thousand CAD | -61.95% |
| 2017 Q2 | -9017.00 CAD | 32.29% |
| 2017 Q1 | -13.31 Thousand CAD | 5.96% |
| 2017 Q4 | -8872.00 CAD | 39.25% |
| 2017 FY | - CAD | -47.22% |
| 2016 Q2 | -10.74 Thousand CAD | 27.51% |
| 2016 FY | - CAD | -174.03% |
| 2016 Q1 | -14.81 Thousand CAD | -2.69% |
| 2016 Q3 | -7561.00 CAD | 29.61% |
| 2016 Q4 | -14.16 Thousand CAD | -87.29% |
| 2015 Q2 | -19.62 Thousand CAD | 20.35% |
| 2015 Q1 | -24.63 Thousand CAD | 18.1% |
| 2015 FY | - CAD | 143.92% |
| 2015 Q4 | -14.43 Thousand CAD | -9.59% |
| 2015 Q3 | -13.16 Thousand CAD | 32.89% |
| 2014 Q4 | -30.07 Thousand CAD | -2.26% |
| 2014 Q3 | -29.41 Thousand CAD | -20.67% |
| 2014 Q2 | -24.37 Thousand CAD | 30.61% |
| 2014 Q1 | -35.12 Thousand CAD | -26.97% |
| 2014 FY | - CAD | 20.87% |
| 2013 Q2 | -38.42 Thousand CAD | -169.19% |
| 2013 Q4 | -27.66 Thousand CAD | 22.94% |
| 2013 Q1 | -14.27 Thousand CAD | 70.42% |
| 2013 FY | - CAD | -45.12% |
| 2013 Q3 | -35.9 Thousand CAD | 6.57% |
| 2012 Q4 | -48.25 Thousand CAD | -98.49% |
| 2012 Q1 | -85.95 Thousand CAD | -1602.71% |
| 2012 Q2 | -7645.00 CAD | 91.11% |
| 2012 Q3 | -24.31 Thousand CAD | -217.99% |
| 2012 FY | - CAD | -3.83% |
| 2011 Q4 | -5048.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 27.519% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -118.966% |
| Blueberries Medical Corp. | -1.22 Million CAD | -260.315% |
| The BC Bud Corporation | -1.19 Million CAD | -268.08% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 32.112% |
| CordovaCann Corp. | -1.6 Million CAD | -174.694% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -67.805% |
| Captor Capital Corp. | 2.42 Million CAD | 281.825% |
| City View Green Holdings Inc. | -2.01 Million CAD | -118.534% |
| 1CM Inc. | 1.31 Million CAD | 435.15% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -17656.173% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -99.343% |
| IM Cannabis Corp. | -2.79 Million CAD | -57.788% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1022.414% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -37.873% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 485.624% |
| Ovation Science Inc. | -778.83 Thousand CAD | -465.242% |
| Pharmadrug Inc. | -1.33 Million CAD | -229.756% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 27.308% |
| RAMM Pharma Corp. | -6.3 Million CAD | 30.146% |
| RIV Capital Inc. | -20.28 Million CAD | 78.293% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 21.318% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 94.326% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -49.194% |
| 1933 Industries Inc. | -10.03 Million CAD | 56.122% |
| Red Light Holland Corp. | -5.25 Million CAD | 16.24% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -473.22% |
| Xebra Brands Ltd. | -1.49 Million CAD | -194.468% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -211.939% |